Literature DB >> 23986251

Synaptic protein α1-takusan mitigates amyloid-β-induced synaptic loss via interaction with tau and postsynaptic density-95 at postsynaptic sites.

Nobuki Nakanishi1, Scott D Ryan, Xiaofei Zhang, Adnan Khan, Timothy Holland, Eun-Gyung Cho, Xiayu Huang, Francesca-Fang Liao, Huaxi Xu, Stuart A Lipton, Shichun Tu.   

Abstract

The synaptic toxicity of soluble amyloid-β (Aβ) oligomers plays a critical role in the pathophysiology of Alzheimer's disease (AD). Here we report that overexpressed α1-takusan, which we previously identified as a protein that enhances synaptic activity via interaction with PSD-95, mitigates oligomeric Aβ-induced synaptic loss. In contrast, takusan knockdown results in enhanced synaptic damage. α1-Takusan interacts with tau either directly or indirectly, and prevents Aβ-induced tau hyperphosphorylation and mitochondrial fragmentation. Deletion analysis identified the second domain (D2) within the takusan protein that is required for PSD-95 clustering and synaptic protection from Aβ. A 51 aa sequence linking D2 to the PDZ-binding C terminus was found to be as effective as full-length takusan in protecting synapses from Aβ-induced damage. Moreover, a sequence containing the D2 from the human protein discs large homolog 5, when linked to a C-terminal PDZ-binding motif, can also increase the clustering of PSD-95 in cortical dendrites. In summary, α1-takusan protects synapses from Aβ-induced insult via interaction with PSD-95 and tau. Thus, takusan-based protein sequences from either mouse or human may be of potential therapeutic benefit in AD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23986251      PMCID: PMC3756761          DOI: 10.1523/JNEUROSCI.4646-10.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  53 in total

1.  Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease.

Authors:  P Hemachandra Reddy; M Flint Beal
Journal:  Trends Mol Med       Date:  2008-01-22       Impact factor: 11.951

2.  Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers.

Authors:  Fernanda G De Felice; Diana Wu; Mary P Lambert; Sara J Fernandez; Pauline T Velasco; Pascale N Lacor; Eileen H Bigio; Jasna Jerecic; Paul J Acton; Paul J Shughrue; Elizabeth Chen-Dodson; Gene G Kinney; William L Klein
Journal:  Neurobiol Aging       Date:  2007-04-02       Impact factor: 4.673

3.  Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of Abeta, and neurodegeneration in a prodromal stage of Alzheimer's disease.

Authors:  Rukhsana Sultana; William A Banks; D Allan Butterfield
Journal:  J Neurosci Res       Date:  2010-02-15       Impact factor: 4.164

Review 4.  Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior.

Authors:  Dennis J Selkoe
Journal:  Behav Brain Res       Date:  2008-02-17       Impact factor: 3.332

5.  Neuroprotection by the NR3A subunit of the NMDA receptor.

Authors:  Nobuki Nakanishi; Shichun Tu; Yeonsook Shin; Jiankun Cui; Toru Kurokawa; Dongxian Zhang; H-S Vincent Chen; Gary Tong; Stuart A Lipton
Journal:  J Neurosci       Date:  2009-04-22       Impact factor: 6.167

6.  Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss.

Authors:  Maria Talantova; Sara Sanz-Blasco; Xiaofei Zhang; Peng Xia; Mohd Waseem Akhtar; Shu-ichi Okamoto; Gustavo Dziewczapolski; Tomohiro Nakamura; Gang Cao; Alexander E Pratt; Yeon-Joo Kang; Shichun Tu; Elena Molokanova; Scott R McKercher; Samuel Andrew Hires; Hagit Sason; David G Stouffer; Matthew W Buczynski; James P Solomon; Sarah Michael; Evan T Powers; Jeffery W Kelly; Amanda Roberts; Gary Tong; Traci Fang-Newmeyer; James Parker; Emily A Holland; Dongxian Zhang; Nobuki Nakanishi; H-S Vincent Chen; Herman Wolosker; Yuqiang Wang; Loren H Parsons; Rajesh Ambasudhan; Eliezer Masliah; Stephen F Heinemann; Juan C Piña-Crespo; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

Review 7.  The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.

Authors:  Xinglong Wang; Bo Su; Ling Zheng; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

8.  S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury.

Authors:  Dong-Hyung Cho; Tomohiro Nakamura; Jianguo Fang; Piotr Cieplak; Adam Godzik; Zezong Gu; Stuart A Lipton
Journal:  Science       Date:  2009-04-03       Impact factor: 47.728

9.  Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes.

Authors:  Jeffrey A Fein; Sophie Sokolow; Carol A Miller; Harry V Vinters; Fusheng Yang; Gregory M Cole; Karen Hoppens Gylys
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

10.  Inhibition of calcineurin-mediated endocytosis and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption.

Authors:  Wei-Qin Zhao; Francesca Santini; Robert Breese; Dave Ross; Xiaohua Douglas Zhang; David J Stone; Marc Ferrer; Matthew Townsend; Abigail L Wolfe; Matthew A Seager; Gene G Kinney; Paul J Shughrue; William J Ray
Journal:  J Biol Chem       Date:  2009-12-23       Impact factor: 5.157

View more
  8 in total

Review 1.  Roles of tau protein in health and disease.

Authors:  Tong Guo; Wendy Noble; Diane P Hanger
Journal:  Acta Neuropathol       Date:  2017-04-06       Impact factor: 17.088

Review 2.  Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease.

Authors:  Cassia R Overk; Eliezer Masliah
Journal:  Biochem Pharmacol       Date:  2014-01-21       Impact factor: 5.858

Review 3.  Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis.

Authors:  Ramesh Kandimalla; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2015-12-17

Review 4.  Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease.

Authors:  Shichun Tu; Shu-ichi Okamoto; Stuart A Lipton; Huaxi Xu
Journal:  Mol Neurodegener       Date:  2014-11-14       Impact factor: 14.195

5.  NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism.

Authors:  Shichun Tu; Mohd Waseem Akhtar; Rosa Maria Escorihuela; Alejandro Amador-Arjona; Vivek Swarup; James Parker; Jeffrey D Zaremba; Timothy Holland; Neha Bansal; Daniel R Holohan; Kevin Lopez; Scott D Ryan; Shing Fai Chan; Li Yan; Xiaofei Zhang; Xiayu Huang; Abdullah Sultan; Scott R McKercher; Rajesh Ambasudhan; Huaxi Xu; Yuqiang Wang; Daniel H Geschwind; Amanda J Roberts; Alexey V Terskikh; Robert A Rissman; Eliezer Masliah; Stuart A Lipton; Nobuki Nakanishi
Journal:  Nat Commun       Date:  2017-11-14       Impact factor: 14.919

Review 6.  The role of pathological tau in synaptic dysfunction in Alzheimer's diseases.

Authors:  Moxin Wu; Manqing Zhang; Xiaoping Yin; Kai Chen; Zhijian Hu; Qin Zhou; Xianming Cao; Zhiying Chen; Dan Liu
Journal:  Transl Neurodegener       Date:  2021-11-10       Impact factor: 8.014

7.  Soluble beta-amyloid peptides, but not insoluble fibrils, have specific effect on neuronal microRNA expression.

Authors:  Jing Jing Li; Georgia Dolios; Rong Wang; Francesca-Fang Liao
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

8.  RPS23RG1 reduces Aβ oligomer-induced synaptic and cognitive deficits.

Authors:  Li Yan; Yaomin Chen; Wubo Li; Xiumei Huang; Hedieh Badie; Fan Jian; Timothy Huang; Yingjun Zhao; Stanley N Cohen; Limin Li; Yun-Wu Zhang; Huanmin Luo; Shichun Tu; Huaxi Xu
Journal:  Sci Rep       Date:  2016-01-06       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.